Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00586911 · ClinicalTrials.gov registry record · Phase 2
Betaine in Patients With Nonalcoholic Steatohepatitis
A Phase 2 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 26
- Enrollment target
NCT00586911: Completed Phase 2 study, sponsored by Mayo Clinic.
NCT00586911 is a Phase 2 study that has completed, run by Mayo Clinic. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00586911, a Phase 2 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 26 participants
- Enrollment target
Study Summary
To assess the safety and efficacy of betaine in patients with NASH on markers of disease severity such as liver histology, liver biochemistries, and health related quality of life.
Interventions
- DRUG Identical Placebo
- DRUG Cystadane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2003-01 |
| Est. Completion | 2006-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00586911
The ClinicalTrials.gov registry entry for NCT00586911 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Identical Placebo is the first listed.
NCT00586911 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00586911 about?
NCT00586911 is a clinical study titled "Betaine in Patients With Nonalcoholic Steatohepatitis". To assess the safety and efficacy of betaine in patients with NASH on markers of disease severity such as liver histology, liver biochemistries, and health related quality of life.
What is the current status of trial NCT00586911?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 26 participants. The study started on 2003-01. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00586911?
The interventions under investigation include: Identical Placebo (DRUG), Cystadane (DRUG).
Who is sponsoring clinical trial NCT00586911?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.